Ten Bio News
It’s just the start of Ten Bio’s journey…
A note from the Chair. I was introduced to Ten Bio’s founders in November 2019. I was immediately engaged by two things: firstly, the logic
Exploring UVC light for virus control
Ten Bio is contributing to a collaborative research project led by the University of St Andrews, funded by Innovate UK, to investigate the use of UVC light in inactivating airborne viruses.
Investment enables Ten Bio to establish new skin testing technology in USA
A near-£1 million investment will help University of Dundee spinout company Ten Bio Ltd to commercialise the human skin culture system it developed to provide
TenSkin used to show effects of filtered far-UVC radiation in skin
Ten Bio’s innovative human skin model, TenSkinTM, features in a recent publication assessing the carcinogenic risk through direct DNA damage of filtered far-UVC exposure. This
Ten Bio win at Scottish Edge
Ten Bio Ltd has won £65,000 in a national competition supporting Scotland’s most exciting new enterprises. Scottish EDGE is the UK’s largest business funding competition,
Converge Challenge prize for Ten Bio
Dr Hickerson was last night named runner-up in the Converge Challenge category of Converge 2020, receiving £29,000 in cash and in-kind business support. Converge is
Ten Bio launched from University of Dundee
Ten Bio launched from University of Dundee Researchers from the University of Dundee are looking to transform pharmaceutical and cosmetics testing with their spinout venture
Wounding response and wound healing in a novel tension-based skin explant model
This study highlights a tensioned ex vivo skin model that maintains viability and replicates in vivo wound healing. Improved keratin expression and 3D visualization confirm its value for studying biomarkers and testing therapies.
A tension-based skin explant model
This study introduces a tensioned ex vivo skin model that maintains viability, structural integrity, and physiological complexity. Unlike traditional models, it replicates in vivo responses, supports toxicity studies, and shows promise for dermatology research and drug discovery, reducing reliance on animal testing.
The advantages of extended viability in TenSkin™ for dermatological research
Ten Bio’s TenSkin™ ex vivo human skin model offers two-week viability, enhancing the depth and reliability of skin studies, allowing for more detailed insights into skin health and treatment efficacy.
A tensioned human skin explant model used for preliminary assessment of chemexfoliant-stimulated bioeffects
Our latest study, using the TenSkinᵀᴹ model, demonstrates how our ex vivo platform is delivering biologically relevant insights into the effects of chemexfoliation (chemical peel) treatments on human skin.
Ten Bio shortlisted for The Courier Business Awards
We are proud to be announced as finalist in The Courier Business Awards in the Innovation and Technology category.
The importance of using a diverse range of skin in aesthetic dermatology testing
The Ten Bio team explore why incorporating all Fitzpatrick types in aesthetic dermatology testing is not just a best practice – it is a scientific imperative.
Preliminary assessment of microneedle wound healing in a full-thickness ex vivo human skin model cultured at physiological tension
This study evaluated skin recovery using the TenSkin™ model after microneedle application (dissolvable and non-dissolving types). Histological and immunofluorescence analyses tracked wound healing, comparing results with laser ablation.
The effect of mechanical tension on bolus morphology and integration following intradermal injection in an ex vivo human skin model
Intradermal injection studies benefit from ex vivo human skin models, but traditional relaxed-state models lack physiological tension, impacting tissue integrity and fiber alignment. The TenSkin™ model addresses this, offering more accurate dermal responses and improved integration of hyaluronic acid-based fillers.